文献速递冠心病外科

冠状动脉旁路移植术后戒烟与中期结局

Smoking Cessation After Surgery and Midterm Outcomes of Surgical Revascularization.
PubMed 文献 · Ann Thorac Surg · 2019-11-07

这项回顾性队列研究纳入2007至2016年在本中心接受单纯冠状动脉旁路移植术(CABG)且术前或术时吸烟的患者9173例,比较术后持续吸烟与持续戒烟者的5年结局。多变量生存分析显示,术后戒烟可降低5年死亡风险35%(HR 0.65,95%CI 0.54-0.77,P<.001)和5年主要不良心脑血管事件风险18%(HR 0.82,95%CI 0.74-0.92,P=.001)。

要点

  • CABG术后持续戒烟与5年死亡风险降低35%相关
  • CABG术后持续戒烟与5年主要不良心脑血管事件风险降低18%相关
  • 应鼓励吸烟患者术后参加戒烟项目

核心结论

  • CABG术后戒烟可显著降低长期死亡率和主要不良事件数量。
  • 吸烟患者术后应被鼓励参加戒烟项目。

研究设计与样本

  • 回顾性队列研究,纳入2007至2016年在本中心接受单纯CABG且术前或术时吸烟的患者。
  • 共9173例当前吸烟者纳入最终分析(93.5%男性,平均年龄58.6岁),术后持续吸烟3302例(40.0%),持续戒烟5688例。

主要发现

  • 多变量生存分析调整主要冠状动脉危险因素后,CABG术后戒烟降低5年死亡率35%(HR 0.65,95%CI 0.54-0.77,P<.001)。
  • CABG术后戒烟降低5年主要不良心脑血管事件18%(HR 0.82,95%CI 0.74-0.92,P=.001)。

临床怎么用

  • 对CABG术后吸烟患者应鼓励参与戒烟项目以改善中期结局。

局限性

  • 本研究为单中心回顾性队列研究,长期结局证据仍存疑问。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although multiple studies have reported the devastating effect of cigarette smoking (CS) on short-term outcomes of patients who underwent coronary artery bypass grafting surgery (CABG), its effect on long-term outcomes is still questionable. We aimed to evaluate the long-term outcomes of CS cessation after CABG surgery. METHODS: This retrospective cohort study included all patients who underwent isolated CABG at our center between 2007 and 2016 and were cigarette smokers either just before or at the time of surgery. Patients were stratified into those who continued CS and those who were persistently CS abstinent after CABG. The endpoints of the study were 5-year mortality and 5-year major adverse cardiovascular and cerebrovascular events. RESULTS: Of 28,945 patients who underwent isolated CABG, 9173 current cigarette smokers (93.5% men; mean age, 58.6 years) met our selection criteria and were included in the final analysis. Of these 3302 patients (40.0%) continued CS after surgery and 5688 patients were persistently abstinent. Multivariable survival analysis demonstrated that CS cessation after CABG, adjusted for major coronary risk factors, could reduce the 5-year mortality by 35% (hazard ratio, 0.65; 95% confidence interval, 0.54-0.77; P < .001) and 5-year major adverse cardiovascular and cerebrovascular events by 18% (hazard ratio, 0.82; 95% confidence interval, 0.74-0.92; P = .001). CONCLUSIONS: Our study shows that CS abstinence after CABG significantly reduces long-term mortality and number of major adverse events. As a result, patients who smoke should be encouraged to participate in CS cessation programs after CABG surgery.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Masoudkabir F, Yavari N, Pashang M, et al. Smoking Cessation After Surgery and Midterm Outcomes of Surgical Revascularization. Ann Thorac Surg. 2019. PMID: 31706875. doi:10.1016/j.athoracsur.2019.09.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。